149 related articles for article (PubMed ID: 29170809)
1. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Hilmi M; Bally C; Burns R; Lorillon G; Bergeron A; Fenaux P; Ades L
Ann Hematol; 2018 Mar; 97(3):541-542. PubMed ID: 29170809
[No Abstract] [Full Text] [Related]
2. Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
Niscola P; Siniscalchi A; Tendas A; Scaramucci L; Fratoni S; de Fabritiis P; Caravita T
Ann Hematol; 2015 Oct; 94(10):1753-4. PubMed ID: 26088814
[No Abstract] [Full Text] [Related]
3. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
Serrao A; Loglisci G; Salaroli A; Zacheo I; Alimena G; Breccia M
Leuk Lymphoma; 2013 Feb; 54(2):411-2. PubMed ID: 22694794
[No Abstract] [Full Text] [Related]
4. A rare case of acquired haemophilia in a patient with chronic myelomonocytic leukaemia successfully treated with decitabine.
Shah D; Kumar R; Gaikazian S
Haemophilia; 2014 Jan; 20(1):e92-4. PubMed ID: 24261579
[No Abstract] [Full Text] [Related]
5. Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.
Rose C; Fournier M; Nibourel O; Herbaux C; Charpentier A; Renneville A; Pissard S; Badens C; Preudhomme C
Leuk Res; 2011 Nov; 35(11):e203-5. PubMed ID: 21831427
[No Abstract] [Full Text] [Related]
6. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?
Breccia M; Voso MT; Alimena G
Leuk Res; 2013 Feb; 37(2):204-5. PubMed ID: 23174191
[No Abstract] [Full Text] [Related]
7. Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.
Niscola P; Tendas A; Abruzzese E; Caravita T; Cupelli L; Giovannini M; Scaramucci L; Siniscalchi A; Trawinska MM; de Fabritiis P
Ann Hematol; 2017 Sep; 96(9):1591-1593. PubMed ID: 28702776
[No Abstract] [Full Text] [Related]
8. [Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case].
Zelada J; Cantó G; Berkovits A; Diocares G; López A
Rev Med Chil; 2015 Nov; 143(11):1490-3. PubMed ID: 26757875
[TBL] [Abstract][Full Text] [Related]
9. A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia.
Drummond MW; Pocock C; Boissinot M; Mills J; Brown J; Cauchy P; Cross NC; Hartley S; Kell J; Szubert A; Cockerill PN; Bowen DT
Leukemia; 2014 Jul; 28(7):1570-2. PubMed ID: 24569776
[No Abstract] [Full Text] [Related]
10. [Treatment of two chronic myelomonocytic leukemia patients with Decitabine].
Wang L; Wang HX; Zhao J
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):497. PubMed ID: 22213878
[No Abstract] [Full Text] [Related]
11. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review.
Thorpe M; Montalvão A; Pierdomenico F; Moita F; Almeida A
Leuk Res; 2012 Aug; 36(8):1071-3. PubMed ID: 22607959
[TBL] [Abstract][Full Text] [Related]
12. Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases.
Hinckley MR; Walsh SN; Molnár I; Sheehan DJ; Sangueza OP; Yosipovitch G
Am J Dermatopathol; 2008 Jun; 30(3):274-7. PubMed ID: 18496432
[TBL] [Abstract][Full Text] [Related]
13. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
[No Abstract] [Full Text] [Related]
14. Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.
Duchmann M; Braun T; Micol JB; Platzbecker U; Park S; Pilorge S; Beyne-Rauzy O; Vey N; Sébert M; Gruson B; Dumas PY; Guieze R; Chretien ML; Laribi K; Chait Y; Legros L; Sahnes L; Hirsch P; Salanoubat C; Solary E; Fenaux P; Itzykson R
Blood Cancer J; 2017 May; 7(5):e562. PubMed ID: 28498370
[No Abstract] [Full Text] [Related]
15. Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment.
Di Battista V; Matteucci C; Pulini S; Calabrese G; Quintini M; Moretti M; Ballanti S; Canino S; Di Bartolomeo P; Mecucci C
Eur J Dermatol; 2017 Oct; 27(5):540-542. PubMed ID: 29084640
[No Abstract] [Full Text] [Related]
16. Optimizing treatments in rare diseases: will our evidence come from registry data?
Almeida AM
Leuk Res; 2014 Apr; 38(4):421-2. PubMed ID: 24631371
[No Abstract] [Full Text] [Related]
17. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.
Fianchi L; Criscuolo M; Breccia M; Maurillo L; Salvi F; Musto P; Mansueto G; Gaidano G; Finelli C; Aloe-Spiriti A; Santini V; Greco M; Hohaus S; Leone G; Voso MT
Leuk Lymphoma; 2013 Mar; 54(3):658-61. PubMed ID: 22873829
[No Abstract] [Full Text] [Related]
18. [Effectiveness of azacitidine in chronic myelomonocytic leukemia harboring del(20q) - a case report].
Manabe M; Okita J; Takakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Gan To Kagaku Ryoho; 2014 Jun; 41(6):781-4. PubMed ID: 25129095
[TBL] [Abstract][Full Text] [Related]
19. Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.
Menter T; Schlageter M; Bastian L; Haberthür R; Rätz Bravo AE; Tzankov A
Hematol Oncol; 2014 Mar; 32(1):47-51. PubMed ID: 23625339
[TBL] [Abstract][Full Text] [Related]
20. Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Pleyer L; Germing U; Sperr WR; Linkesch W; Burgstaller S; Stauder R; Girschikofsky M; Schreder M; Pfeilstocker M; Lang A; Sliwa T; Geissler D; Schlick K; Placher-Sorko G; Theiler G; Thaler J; Mitrovic M; Neureiter D; Valent P; Greil R
Leuk Res; 2014 Apr; 38(4):475-83. PubMed ID: 24522248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
